VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 701 filers reported holding VANECK VECTORS ETF TR in Q2 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $242,055 | -67.0% | 8,995 | -63.0% | 0.03% | -64.0% |
| Q2 2023 | $732,426 | -6.9% | 24,325 | 0.0% | 0.09% | -6.3% |
| Q1 2023 | $786,914 | +6.3% | 24,325 | -5.8% | 0.10% | +5.6% |
| Q4 2022 | $740,145 | +93.2% | 25,825 | +84.5% | 0.09% | +87.5% |
| Q2 2022 | $383,000 | -79.3% | 14,000 | -71.0% | 0.05% | -76.4% |
| Q1 2022 | $1,853,000 | +182.0% | 48,325 | +135.7% | 0.20% | +141.7% |
| Q4 2021 | $657,000 | +8.8% | 20,500 | -0.0% | 0.08% | +2.4% |
| Q3 2021 | $604,000 | -69.1% | 20,501 | -64.3% | 0.08% | -65.3% |
| Q2 2021 | $1,952,000 | +4.6% | 57,450 | 0.0% | 0.24% | +33.3% |
| Q1 2021 | $1,867,000 | -57.6% | 57,450 | -53.0% | 0.18% | -69.9% |
| Q4 2020 | $4,400,000 | -14.3% | 122,150 | -6.9% | 0.59% | -27.7% |
| Q3 2020 | $5,136,000 | +162.7% | 131,150 | +146.1% | 0.82% | +159.6% |
| Q2 2020 | $1,955,000 | +67.2% | 53,300 | +5.0% | 0.31% | +42.1% |
| Q1 2020 | $1,169,000 | +19.2% | 50,750 | +51.5% | 0.22% | +46.4% |
| Q4 2019 | $981,000 | +7.0% | 33,500 | -2.5% | 0.15% | +1.3% |
| Q3 2019 | $917,000 | +15.1% | 34,350 | +10.1% | 0.15% | +12.9% |
| Q2 2019 | $797,000 | +28.8% | 31,200 | +13.0% | 0.13% | +25.7% |
| Q1 2019 | $619,000 | +172.7% | 27,600 | +156.4% | 0.10% | +144.2% |
| Q4 2018 | $227,000 | +14.6% | 10,763 | +0.6% | 0.04% | +34.4% |
| Q3 2018 | $198,000 | -17.2% | 10,700 | 0.0% | 0.03% | -20.0% |
| Q2 2018 | $239,000 | +1.7% | 10,700 | 0.0% | 0.04% | +11.1% |
| Q1 2018 | $235,000 | -5.6% | 10,700 | 0.0% | 0.04% | -7.7% |
| Q4 2017 | $249,000 | +1.2% | 10,700 | 0.0% | 0.04% | -2.5% |
| Q3 2017 | $246,000 | +4.2% | 10,700 | 0.0% | 0.04% | +2.6% |
| Q2 2017 | $236,000 | -3.3% | 10,700 | 0.0% | 0.04% | 0.0% |
| Q1 2017 | $244,000 | +8.9% | 10,700 | 0.0% | 0.04% | +5.4% |
| Q4 2016 | $224,000 | -20.8% | 10,700 | 0.0% | 0.04% | -24.5% |
| Q3 2016 | $283,000 | -11.8% | 10,700 | -7.8% | 0.05% | -9.3% |
| Q2 2016 | $321,000 | – | 11,600 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
| Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
| Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
| New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
| Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
| Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
| Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
| Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
| Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |